reference/1929643

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1929643

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial
endingPage	1270
issn	1177-8881
pageRange	1259-1270
publicationName	Drug Design, Development and Therapy
startingPage	1259
bibliographicCitation	Reisman SA, Gahir SS, Lee CI, Proksch JW, Sakamoto M, Ward KW. Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates. Drug Des Devel Ther. 2019;13():1259–70. PMID: 31118567; PMCID: PMC6475100.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd40024c38ef68baac195a1d44d3a861 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c367e67738d39fb829eac8e241608b72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d370d389c638f7eb01280d1f49b852a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83a8fdb817b16f57deb039f4fd90d92c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ecf07d4fab258160b75fa53f9b103c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c39e0e78c4e5b43e3d5474770cb58f7b
date	201904
identifier	https://pubmed.ncbi.nlm.nih.gov/31118567 https://pubmed.ncbi.nlm.nih.gov/PMC6475100 https://doi.org/10.2147/dddt.s193889
isPartOf	https://portal.issn.org/resource/ISSN/1177-8881 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36020
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates
discusses	http://id.nlm.nih.gov/mesh/M0479977 http://id.nlm.nih.gov/mesh/M000682257 http://id.nlm.nih.gov/mesh/M0237441 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0022020
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D051267Q000378 http://id.nlm.nih.gov/mesh/D005621Q000188 http://id.nlm.nih.gov/mesh/D014315Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051267Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D008252 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D014315Q000737 http://id.nlm.nih.gov/mesh/D012333Q000378 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D014315Q000008 http://id.nlm.nih.gov/mesh/D012333Q000235 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d8efb5335a904318b9014eccec9d3e9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7783 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548717 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451674 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71811910 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f56a221bc770a5fa884ac7d3634f29a8

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223365909 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4780

Total number of triples: 53.